The importance of understanding the genetics of female carriers, the prevalence of clinical symptoms and how they’re caused, and the services available for symptomatic and non-symptomatic carriers.
February 2, 2024 by Lizzie Deeble
February 2, 2024 by Lizzie Deeble
Action Duchenne
Wellesley House
Duke of Wellington Avenue Royal Arsenal
London
SE18 6SS
07535 498 506
info@actionduchenne.org